Category: Announcements

CybernaX announces a lipid licensing agreement with Merck KGaA, Darmstadt, Germany

24 July 2024 — CybernaX today announced a licensing agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company headquartered in Darmstadt, covering the proprietary high-performance lipid library developed in house by CybernaX. The collaboration centers…

Read more →

CybernaX and CanSino (Shanghai) partner on nucleic acid medicines for the global animal health market

9 July 2024 — CybernaX Biotechnologies announced that it has entered into a licensing and collaboration agreement with CanSino (Shanghai) Biological Technology Co., Ltd. covering lipid development for veterinary infectious disease vaccines. Under the agreement, CybernaX will supply…

Read more →